Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty
This study has been completed.
Study NCT00420277   Information provided by Sangart

First Received on January 9, 2007.   Last Updated on August 30, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypotension
Ischemia
More general conditions related to this trial
Cardiovascular Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
MalPEG-Hb (Hemospan)
6% hetastarch solution (Voluven)
Additional drug interventions recognized in this trial
Hetastarch
More general drug interventions related to this trial
Blood Substitutes
Hematologic Agents
Pharmacologic Actions
Plasma Substitutes
Therapeutic Uses
Sponsors listed in this trial
Sangart


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services